TK001
Sponsors
Jiangsu T-Mab Biopharma Co.,Ltd
Conditions
Neovascular Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Phase 1
Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration
NCT02613559
Start: 2015-11-30End: 2018-09-30Target: 27Updated: 2018-03-01
A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration
NCT03021785
Start: 2017-10-18End: 2018-11-30Target: 36Updated: 2018-03-01